Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Support Palliat Care. 2008 Sep;2(3):211-7. doi: 10.1097/SPC.0b013e32830d5c12.

Hematopoietic niche and bone meet.

Author information

  • 1Endocrine Division, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

Abstract

PURPOSE OF REVIEW:

To provide an overview of the hematopoietic stem cell (HSC) niche in the bone marrow. In addition to highlighting recent advances in the field, we will also discuss components of the niche that may contribute to the development of cancer, or cancer metastases to the bone.

RECENT FINDINGS:

Much progress has been very recently made in the understanding of the cellular and molecular interactions in the HSC microenvironment. These recent findings point out the extraordinary complexity of the HSC microenvironment. Emerging data also suggest convergence of signals important for HSC and for leukemia or metastatic disease support.

SUMMARY:

The HSC niche comprises complex interactions between multiple cell types and molecules requiring cell-cell signaling as well as local secretion. These components can be thought of as therapeutic targets not only for HSC expansion, but also to modify behavior of hematopoietic malignancies and cancer metastases to the bone.

PMID:
18685423
[PubMed - indexed for MEDLINE]
PMCID:
PMC2572865
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk